A. Estellés

No ORCID on file · 10 papers in corpus · active 2003-2014

Study types

  • article 8
  • other 1
  • review 1

Condition tags

  • endometriosis 10
  • endometrioma 3
article 2014
C0418: miRNAs 16, 424 and 29C Regulate VEGF-A Expression in Endometrial Stromal Cells from Women with Endometriosis
·doi:10.1016/s0049-3848(14)50066-7
review 2012
Role of microRNAs in Gynecological Pathology
Current medicinal chemistry ·doi:10.2174/092986712800269362

microRNAs (miRNAs) are 21-22 nucleotide non-coding RNAs that regulate gene expression and play fundamental roles in biological processes. These small molecules bind to target mRNAs, leading to translational repression and/or mRNA degradatio…

article 2011
microRNAs expression in endometriosis and their relation to angiogenic factors
Human Reproduction ·doi:10.1093/humrep/der025

BACKGROUND: Endometriosis is a common, multifactorial disease in which angiogenesis may be involved in the growth of endometrium outside the uterus. microRNAs (miRNAs) are 21-22 nucleotide non-coding RNAs that regulate gene expression and p…

article 2009
Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis
Human Reproduction ·doi:10.1093/humrep/dep419

BACKGROUND: Endometriosis, defined as the presence of endometrium outside the uterus, is one of the most frequent benign gynaecological diseases. It has been suggested that both endometrial and peritoneal factors, related to angiogenesis an…

article 2009
O4 Vascular endothelial growth factor (VEGF) polymorphisms (−460C/T, +405G/C and 936C/T) and endometriosis. Their influence on VEGF expression
·doi:10.1016/s0049-3848(09)70029-5
article 2007
ANGIOGENESIS IN ENDOMETRIOSIS. INFLUENCE OF THREE FUNCTIONAL VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) POLYMORPHISMS (−460CT, 405GC AND 936CT) IN VEGF EXPRESSION
·doi:10.1111/j.1538-7836.2007.tb00521.x
other 2007
Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems
Human Reproduction ·doi:10.1093/humrep/dem149

BACKGROUND: Endometriosis is a highly prevalent, benign disease in which the angiogenic, fibrinolytic and metalloproteinase (MMP) systems may be implicated. The objective of this study is to analyse mRNA expression and protein levels of sev…

article 2004
mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT–PCR assay
Human Reproduction ·doi:10.1093/humrep/deh571

BACKGROUND: The plasminogen activator (PA) and matrix metalloproteinase (MMP) systems are implicated in the establishment of endometriosis. The mechanisms by which these systems are involved in the pathogenesis of this disease are not well …

article 2003
Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis
Human Reproduction ·doi:10.1093/humrep/deg300

BACKGROUND: Endometriosis is considered a benign disease that has the ability to invade normal tissue. As in neoplastic growth, local extracellular proteolysis may take place. The aim of this study is to analyse several components of the pl…

article 2003
Quantitative real-time reverse transcription-PCR (RT-PCR) assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1 and tissue metalloproteinase inhibitor type 1 gene expression and protein levels in endometriosis
·doi:10.1111/j.1538-7836.2003.tb04369.x